The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Temozolomide Clonmel 20 mg hard capsules

20 milligram(s) Capsule, hard

Clonmel Healthcare LtdPA0126/188/002

Main Information

Trade NameTemozolomide Clonmel 20 mg hard capsules
Active SubstancesTemozolomide
Strength20 milligram(s)
Dosage FormCapsule, hard
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/188/002

Group Information

ATC CodeL01AX Other alkylating agents
L01AX03 temozolomide


Licence Issued21/05/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListTemozolomide 20mg Capsules
Interchangeable List CodeIC0080-003-001
Interchangeable List DocumentPDF of Interchangeable List
« Back